ERT and Bioclinica MergeREAD MORE
ERT ANNOUNCES READ MORE
REINVENTING ENDPOINT LEARN MORE
VIRTUAL VISITSLEARN MORE
A BETTER WAY TO LEARN MORE
A BETTER WAY TO
MINIMIZE RISK AND UNCERTAINTY
We deliver the flexibility and adaptability you need to overcome challenges for faster speed to market. Here’s how:
NEWS & EVENTS
December 10, 2020
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology PHILADELPHIA ...
December 22, 2020
ERT’s Year in Review: 11 Pieces You Don’t Want to Miss
2020 was a year of evolution in the clinical research industry. In the face of unexpected and unprecedented challenges, we were inspired to adapt.
September 29, 2020
FDA Guidance Overview: Assessing Symptoms in Clinical Trials Aimed to Prevent and Treat COVID-19
Learn the FDA’s position on assessing symptoms in clinical trials of drugs and biologics for the prevention and treatment of COVID-19.